Home » Topics » BioWorld Science

BioWorld Science
RSS

Protein is marker, target for diabetic neuropathy

March 30, 2022

Alpha Cognition reports in vivo and in vitro data on ALPHA-0602 for ALS

March 30, 2022

Novel ferroptosis inhibitor mitigates cerebral ischemic injury in rat

March 30, 2022

Cybin completes in vivo studies for deuterated psilocybin analogue CYB-003 for MDD

March 30, 2022

Ube Industries and HiLung to codevelop LPA1 antagonist HL-001 for IPF

March 30, 2022

AMG-650: a first-in-class KIF18A inhibitor for the treatment of chromosomally unstable cancers

March 30, 2022

Pimavanserin exerts anticancer effects via autophagy-mediated apoptosis

March 30, 2022

New antifungals synthesized at Kyung Hee University

March 30, 2022

Wuhan LL Science and Technology Development presents new MAPK8 inhibitors

March 30, 2022

Apoptosis regulator BAX inhibitors patented by Albert Einstein College of Medicine

March 30, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...